ENTtoday
  • Home
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Endoscopic Sinus Surgery More Cost-Effective than Dupilumab in Treatment of Patients with Rhinosinusitis with Nasal Polyps

by Linda Kossoff • March 15, 2023

  • Tweet
  • Email
Print-Friendly Version

What is the cost-effectiveness of dupilumab as compared to endoscopic sinus surgery (ESS) in the treatment of patients with chronic rhinosinusitis with nasal polyps (CRSwNP) refractory to medical therapy?

BOTTOM LINE

You Might Also Like

No related posts.

Explore This Issue
March 2023

While dupilumab and ESS may demonstrate similar clinical effectiveness, ESS remains the more cost-effective option for patients with CRSwNP refractory to medical therapy.

BACKGROUND: Dupilumab is a novel monoclonal antibody that shows promise in treating patients with CRSwNP who fail initial medical management. ESS, the mainstay therapy for CRSwNP, has been shown to be clinically effective and cost-effective when compared to long-term medical management. Data comparing the cost-effectiveness of ESS and dupilumab is scarce.

STUDY DESIGN: Cohort-style evaluation.

SETTING: Department of Otolaryngology–Head and Neck Surgery, University of South Florida Morsani College of Medicine, Tampa, Fla.

SYNOPSIS: Researchers created a decision tree microsimulation model in which patients with CRSwNP were assigned to either dupilumab or ESS, after which they entered a Markov model specific to that treatment. Patients who entered the dupilumab arm who responded (experienced a continued clinical benefit) to treatment continued to receive the therapy; those who did not respond to treatment underwent surgery followed by maintenance treatment or revision surgery if needed. Patients who entered the surgery arm either followed maintenance treatment or underwent revision surgery if needed. Effectiveness was measured using Sino-Nasal Outcome Test scores. The average effectiveness of dupilumab and surgery, measured as quality-adjusted life-year over the 10 model years, was 1.779 and 1.526, respectively. Modeled from the payer perspective, over the 10 years, the average lifetime costs of the dupilumab and surgery were $195,164 and $20,549, respectively. Although dupilumab therapy showed somewhat greater overall effectiveness, in the long term, ESS was the more cost-effective option. Dupilumab treatment requires two-week dosing, so the chronicity of treatment, compounded with high drug pricing, creates high healthcare consumption. Study limitations included a lack of data on dupilumab application.

CITATION: Parasher AK, Gliksman M, Segarra D, et al. Economic evaluation of dupilumab versus endoscopic sinus surgery for the treatment of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2022;12:813–820.

Filed Under: Literature Reviews, Practice Focus, Rhinology, Rhinology Tagged With: clinical outcomesIssue: March 2023

You Might Also Like:

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Second Victims: The Effects of a Medical Error on Physicians Can Be Devastating
    • Advanced Degrees Can Help Otolaryngologists Better Understand the Business of Medicine
    • How to: A Dynamic Endonasal Columellar Strut Placement
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • Vertigo in the Elderly: What Does It Mean?
    • What Happens to Medical Students Who Don’t Match?
    • Complications for When Physicians Change a Maiden Name
    • Qualitative Research Shows How Patients Feel About Quality-of-Life Issues
    • How to: A Dynamic Endonasal Columellar Strut Placement
    • Second Victims: The Effects of a Medical Error on Physicians Can Be Devastating
    • Advanced Degrees Can Help Otolaryngologists Better Understand the Business of Medicine
    • Laser Laryngeal Surgery Is Safe Under THRIVE

Polls

Have you ever been, or have you ever known someone who has been a second victim?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2023 The Triological Society. All Rights Reserved.
ISSN 1559-4939